[Evaluation of amyxin effect in prophylaxis of acute respiratory viral infections].
The results of the evaluation of the oral inductor of endogenic interferon (amyxin), manufactured in Russia are presented. The use of amyxin was found to produce a drop in morbidity in acute respiratory virus infections (ARVI) among medical workers 3.4 times, i.e. the preparation exhibited a pronounced prophylactic effect with respect to ARVI. The use of the preparation was accompanied by a decrease in the number of manifest forms of ARVI. Persons given the preparation often had ARVI in a mild or asymptomatic form.
Sel'kova
E P
EP
Botkin City Clinical Hospital, Gamaleya Research Institute of Epidemiology and Mikrobiology, Medical Academy of Post-Diploma Education, Central State Sanitary and Epidemiological Inspection, Moscow, Russia.
Iakovlev
V N
VN
Semenenko
T A
TA
Filatov
N N
NN
Gotvianskaia
T P
TP
Danilina
G A
GA
Pantiukhova
T N
TN
Nikitina
G Iu
GIu
Tur'ianov
M Kh
MKh
D000208:Acute Disease; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D009031:Moscow / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000517:prevention & control*; D013994:Tilorone / Q000627:therapeutic use*; D014777:Virus Diseases / Q000453:epidemiology / Q000517:prevention & control*
D007369:Interferon Inducers; D013994:Tilorone